Perhaps I heard wrong, but I recall NP saying on t
Post# of 148162
Like others have said, this is the first I've ever heard that the phase 2 had any intern result review provision. So maybe NP misspoke but I'd think he'd have a good handle on this type of stuff.
NP also went on to say something to the effect of performing a review sooner if the FDA was open to that, seemingly suggesting that these trial review timelines are negotiable.